Immunomodulatory Effect of Curcumin in the Upregulation of Inflammasome Pathway Genes Induced by Sulfur Mustard Analog: An In-vitro Study.
A549 Cells
Anti-Inflammatory Agents
/ pharmacology
Caspase 1
/ genetics
Curcumin
/ pharmacology
Gene Expression Regulation
/ drug effects
Humans
Immunologic Factors
/ pharmacology
Inflammasomes
/ genetics
Interleukin-1beta
/ genetics
Mustard Gas
/ analogs & derivatives
NF-kappa B p50 Subunit
/ genetics
NLR Proteins
/ genetics
Signal Transduction
/ drug effects
Up-Regulation
/ drug effects
2-chloroethyl ethyl sulfide
Curcumin
Genes
Inflammasomes
Sulfur mustard
Journal
Iranian journal of allergy, asthma, and immunology
ISSN: 1735-5249
Titre abrégé: Iran J Allergy Asthma Immunol
Pays: Iran
ID NLM: 101146178
Informations de publication
Date de publication:
17 Apr 2021
17 Apr 2021
Historique:
received:
11
10
2020
accepted:
30
12
2020
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
10
11
2021
Statut:
epublish
Résumé
Sulfur Mustard (SM) induces cell injury via exerting oxidative stress, protease-anti protease imbalance, and inflammation. Inflammasome as one part of innate immunity has a critical role in the recognition of cell injuries and the initiation of the inflammation process by releasing IL-1β. Hence, the present study investigated the effects of the sub-lethal doses of 2-chloroethyl ethyl sulfide (CEES) as SM analog on the gene expression level of inflammasome-related genes as well as the potential protective effects of curcumin on this process. The effects of sub-lethal doses (500, 1000, and 2500 mM) of CEES on pulmonary epithelial cell line (A549) were determined at various time points (12, 24, and 48 h). Following the treatment of cells with CEES, the kinetic alterations of the expression levels of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB1), NLR family pyrin domain containing 1 (NLRP1), Caspase-1 (Casp1), and Interleukin-1β (IL-1β) genes were analyzed; using real-time PCR. In addition, the concurrent protective effects of different doses of curcumin (20, 40, 80, and 160 mM) on modulating the effects of CEES were studied. Although it was found that the lowest sub-lethal dose of CEES (500 mM) was able to up-regulate the inflammasome-related genes, the maximum alterations occurred 48 h after the treatment with the higher sub-lethal dose (2500 mM) of CEES. The maximum alteration occurred in Casp1 (38 fold), IL-1β (19 fold), and NLRP1 (~4 fold) genes (p<0.0001). However, the NF-ĸB gene expression level did not alter following CEES exposure. Even though low doses of curcumin (20, 40, and 80 mM) were able to down-regulate the studied genes, it was found that the treatment of cells with 160 mM of curcumin for 48 h was able to normalize the expression level of all genes. The present study concludes that curcumin as an anti-inflammatory agent may have beneficial immunomodulatory effects following CEES exposure.
Substances chimiques
Anti-Inflammatory Agents
0
IL1B protein, human
0
Immunologic Factors
0
Inflammasomes
0
Interleukin-1beta
0
NF-kappa B p50 Subunit
0
NFKB1 protein, human
0
NLR Proteins
0
NLRP1 protein, human
0
2-chloroethyl ethyl sulfide
693-07-2
Caspase 1
EC 3.4.22.36
Curcumin
IT942ZTH98
Mustard Gas
T8KEC9FH9P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM